A retrospective study found higher cardiovascular event rates among women starting testosterone therapy, but researchers say it cannot show the treatment caused them.
Psilocybin Tied To Lower Inflammation In Parkinson’s Trial
A nonrandomized trial of 12 people with Parkinson’s found lower inflammation markers after psilocybin, but the findings need larger controlled studies.
Ianalumab’s Road To Approval For Sjogren’s Looks Bumpier
Published phase III results show small improvements in disease activity but no clear benefit on several key symptoms; Novartis has started another trial.